Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for children with Phelan-McDermid syndrome
NL-OMON37136Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin in Phelan-McDermid syndrome (PMS) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Developmental pace. Started Feb 2013; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
Phelan-McDermid syndrome (PMS)
Beyond the preview
Go deeper on NL-OMON37136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37136.